Suchergebnisse - (Standardsuche:ritonavir)

PubPharm (192)

61

ARIES 144 week results : durable virologic suppression in HIV-infected patients simplified to unboosted atazanavir/abacavir/lamivudine

enthalten in: HIV clinical trials | 2012

von Squires, K. | Young, B. | DeJesus, E. | +64

CommentIn: HIV Clin Trials. 2015 Aug;16(4):125-9. - PMID 26133089

62

Effect of darunavir on lipid profile in HIV-infected patients

enthalten in: HIV clinical trials | 2012

von Overton, E. | Arathoon, E. | Baraldi, E. | +1

63

A pilot, prospective, open-label simplification study to evaluate the safety, efficacy, and pharmacokinetics of once-daily lopinavir-ritonavir monotherapy in HIV-HCV coinfected patients : the MONOCO study

enthalten in: HIV clinical trials | 2012

von Cooper, C. | la Porte, C. | Tossonian, H. | +3

64

Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in HIV-infected patients treated with ritonavir-boosted protease inhibitors

enthalten in: HIV clinical trials | 2012

von Calza, L. | Trapani, F. | Bartoletti, M. | +6

65

A nucleoside- and ritonavir-sparing regimen containing atazanavir plus raltegravir in antiretroviral treatment-naïve HIV-infected patients : SPARTAN study results

enthalten in: HIV clinical trials | 2012

von Kozal, M. | Lupo, S. | DeJesus, E. | +17

66

Hepatic safety profile of fosamprenavir-containing regimens in HIV-1-infected patients with or without hepatitis B or C coinfection

enthalten in: HIV clinical trials | 2012

von Ha, B. | Wine, B. | Rodriguez-Alcantra, F. | +1

67

Liver toxicity of initial antiretroviral drug regimens including two nucleoside analogs plus one non-nucleoside analog or one ritonavir-boosted protease inhibitor in HIV/HCV-coinfected patients

enthalten in: HIV clinical trials | 2012

von Macías, J. | Neukam, K. | Mallolas, J. | +28

68

Impact of baseline virologic, immunologic, and demographic characteristics on virologic responses in the Gemini study

enthalten in: HIV clinical trials | 2012

von Avihingsanon, A. | Ruxrungtham, K. | Katner, H. | +2

69

Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected Patients

enthalten in: HIV clinical trials | 2012

von Macías, J. | Neukam, K. | Mallolas, J. | +13

70

A Nucleoside- and Ritonavir-Sparing Regimen Containing Atazanavir Plus Raltegravir in Antiretroviral Treatment-Naïve HIV-Infected Patients: SPARTAN Study Results

enthalten in: HIV clinical trials | 2012

von Kozal, M. | Lupo, S. | DeJesus, E. | +16